Mary Rinella to Carcinoma, Hepatocellular
This is a "connection" page, showing publications Mary Rinella has written about Carcinoma, Hepatocellular.
Connection Strength
0.952
-
Nonalcoholic Fatty liver disease, diabetes, obesity, and hepatocellular carcinoma. Clin Liver Dis. 2015 May; 19(2):361-79.
Score: 0.323
-
Implementation of a liver health check in people with type 2 diabetes. Lancet Gastroenterol Hepatol. 2024 01; 9(1):83-91.
Score: 0.149
-
Non-alcoholic fatty liver disease. Lancet. 2021 06 05; 397(10290):2212-2224.
Score: 0.123
-
Systematic review with meta-analysis: risk of hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis compared to other liver diseases. Aliment Pharmacol Ther. 2018 10; 48(7):696-703.
Score: 0.102
-
NAFLD in 2014: Genetics, diagnostics and therapeutic advances in NAFLD. Nat Rev Gastroenterol Hepatol. 2015 Feb; 12(2):65-6.
Score: 0.080
-
Clinical Outcomes and Non-Invasive Testing in Metabolic Dysfunction-Associated Steatohepatitis With Cirrhosis: A Systematic Review. Liver Int. 2026 05; 46(5):e70608.
Score: 0.044
-
The Relentless Progression of Metabolic Dysfunction-associated Steatotic Liver Disease in Liver Transplantation in Spain. Transplantation. 2026 Feb 01; 110(2):e444-e452.
Score: 0.042
-
Risk of hepatic and extrahepatic outcomes associated with metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction and alcohol-associated steatotic liver disease: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2025 11; 10(11):998-1012.
Score: 0.042
-
Liver Transplantation for Nonalcoholic Steatohepatitis: Pathophysiology of Recurrence and Clinical Challenges. Dig Dis Sci. 2019 12; 64(12):3413-3430.
Score: 0.027
-
Nonalcoholic fatty liver disease. Nat Rev Dis Primers. 2015 12 17; 1:15080.
Score: 0.021